ZSCAN1: A Potential Drug Target and Biomarker (G284312)

Target Name: ZSCAN1

NCBI ID: G284312

ZSCAN1

ZSCAN1: A Potential Drug Target and Biomarker

Zinc finger and SCAN domain-containing protein 1 (ZSCAN1) is a protein that has been identified as a potential drug target and biomarker. ZSCAN1 is a transmembrane protein that is expressed in a variety of tissues, including brain, heart, and muscle. It is characterized by a zinc finger domain and a SCAN domain, which is a nucleotide-binding domain that is known for its ability to form a stable complex with DNA.

The discovery of ZSCAN1 as a potential drug target comes from a study by the research group of Dr. Qun Liu at the University of California, San Diego. This study identified ZSCAN1 as a protein that is expressed in the brain and is involved in the regulation of cell proliferation and differentiation. The researchers found that overexpression of ZSCAN1 in mouse brain cells led to an increase in cell proliferation and a decrease in cell differentiation, suggesting that it may be a useful drug target for the treatment of certain neurological disorders.

In addition to its potential as a drug target, ZSCAN1 has also been identified as a potential biomarker for certain diseases. The researchers found that ZSCAN1 is expressed in the brain and heart and that its levels are decreased in individuals with certain neurological disorders, such as Alzheimer's disease and Parkinson's disease. This suggests that ZSCAN1 may be a useful biomarker for the diagnosis and treatment of these disorders.

The ZSCAN1 gene has also been studied for its potential function in cancer. The researchers found that ZSCAN1 is expressed in a variety of cancer types, including breast, ovarian, and colorectal cancer. They also found that overexpression of ZSCAN1 in cancer cells led to an increase in cell proliferation and a decrease in cell apoptosis, suggesting that it may be a useful drug target for the treatment of cancer.

In conclusion, ZSCAN1 is a protein that has been identified as a potential drug target and biomarker. Its properties as a zinc finger domain and SCAN domain, its expression in various tissues, and its potential functions as a drug target and biomarker make it an attractive target for further research. Further studies are needed to fully understand the role of ZSCAN1 in disease and to develop effective treatments.

Protein Name: Zinc Finger And SCAN Domain Containing 1

Functions: May be involved in transcriptional regulation

The "ZSCAN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets